Illumina, Inc. (LON:0J8Z)
London · Delayed Price · Currency is GBP · Price in USD 97.91
+1.94 (2.02%)
At close: Oct 30, 2025
Illumina Employees
As of December 29, 2024, Illumina had 9,030 total employees, including 8,970 full-time and 60 part-time employees. The number of employees decreased by 1,610 or -15.13% compared to the previous year.
Employees
9,030
Change (1Y)
-1,610
Growth (1Y)
-15.13%
Revenue / Employee
355.28K GBP
Profits / Employee
58.25K GBP
Market Cap
14.46B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 9,030 | -1,610 | -15.13% |
| Dec 31, 2023 | 10,640 | -920 | -7.96% |
| Jan 1, 2023 | 11,560 | 1,710 | 17.36% |
| Jan 2, 2022 | 9,850 | 2,000 | 25.48% |
| Jan 3, 2021 | 7,850 | 150 | 1.95% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Illumina News
- 11 days ago - Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 Earnings - Seeking Alpha
- 17 days ago - Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights - PRNewsWire
- 17 days ago - Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot - PRNewsWire
- 18 days ago - Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 - PRNewsWire
- 25 days ago - Illumina (ILMN) Shares Cross Below 200 DMA - Nasdaq
- 25 days ago - Illumina (ILMN) Analyst Rating Update: Evercore ISI Lowers Price Target | ILMN Stock News - GuruFocus
- 25 days ago - Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Nasdaq
- 4 weeks ago - ILMN Stock Set to Benefit From the Launch of New BioInsight Division - Nasdaq